Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Smreti Vasudevan
Germline BRCA1 and BRCA2 Deleterious Mutations and Variants of Unknown Clinical Significance Associated With Breast/Ovarian Cancer: A Report From North India
Cancer Management and Research
Oncology
Related publications
Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations
Annals of Surgical Oncology
Oncology
Surgery
Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
BRCA1 and BRCA2 Mutations and Clinical Interpretation in 398 Ovarian Cancer Patients: Comparison With Breast Cancer Variants in a Similar Population
Human Genomics
Molecular Medicine
Drug Discovery
Genetics
Molecular Biology
BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Intron Variants of the P53 Gene Are Associated With Increased Risk for Ovarian Cancer but Not in Carriers of BRCA1 or BRCA2 Germline Mutations
British Journal of Cancer
Cancer Research
Oncology
Hereditary Breast Cancer: Mutations Within BRCA1 and BRCA2 With Phenotypic Responses
Biallelic Deleterious BRCA1 Mutations in a Woman With Early-Onset Ovarian Cancer
Cancer Discovery
Oncology
Prevalence of BRCA1 and BRCA2 Mutations in Breast Cancer Patients From Brazil
Breast Cancer Research and Treatment
Cancer Research
Oncology
A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women With Ovarian Cancer
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental